A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/23/2009	WO2009154777A2 Process for preparing and drying solid rasagiline base
12/23/2009	WO2009154775A1 S1p1 receptor agonists and use thereof
12/23/2009	WO2009154769A1 Substituted pyridazine carboxamide compounds as kinase inhibitor compounds
12/23/2009	WO2009154766A1 Renin inhibitors and method of use thereof
12/23/2009	WO2009154762A1 New fixed dose pharmaceutical composition comprising hydroxyurea and didanosine
12/23/2009	WO2009154754A2 Synthesis of deuterated morpholine derivatives
12/23/2009	WO2009154741A1 Thiophene or thiazole derivatives and their use as pi3k inhibitors
12/23/2009	WO2009154739A2 Smoothened receptor modulators
12/23/2009	WO2009154697A2 Disc-1 pathway activators in the control of neurogenesis
12/23/2009	WO2009154648A1 Polyamine enhanced formulations for triptan compound iontophoresis
12/23/2009	WO2009154646A1 Dual drug formulations for implantable medical devices for treatment of vascular diseases
12/23/2009	WO2009154645A1 Methods for the treatment of central nervous system tumors
12/23/2009	WO2009154610A1 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
12/23/2009	WO2009154579A1 A digoxin-like fungal glycoside with cytotoxic properties: novel assay and applications
12/23/2009	WO2009154565A1 Combination therapies against cancer
12/23/2009	WO2009154563A1 Dibenzothiazepine derivatives and use thereof
12/23/2009	WO2009154562A1 Pharmaceutical composition comprising a 4-hydroxy-2-oxo-2, 3- dihydro-1, 3-benzothiazol-7-yl compound for modulation of beta2-adrenoreceptor activity
12/23/2009	WO2009154557A1 Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders
12/23/2009	WO2009154555A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a beta2-adrenoceptor agonist
12/23/2009	WO2009154554A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a second active ingredient
12/23/2009	WO2009154505A1 Membrane stabilising agent
12/23/2009	WO2009154460A1 Modulation of memory function.
12/23/2009	WO2009154304A2 A pharmaceutical composition
12/23/2009	WO2009154280A1 Agent for preventing excessive appetite
12/23/2009	WO2009154276A1 Crystal of spiroketal derivative, and process for production thereof
12/23/2009	WO2009154248A1 Pharmaceutical composition for treatment or prevention of hbv infection
12/23/2009	WO2009154246A1 Therapeutic agent for erectile dysfunction
12/23/2009	WO2009154237A1 Stabilizer for lymph vessel
12/23/2009	WO2009154230A1 Prophylactic/ameliorating or therapeutic agent for non-alcoholic steatohepatitis
12/23/2009	WO2009154197A1 Cognitive disorder-ameliorating agent
12/23/2009	WO2009154190A1 Pyridone compound
12/23/2009	WO2009154148A1 Analgesic anti-inflammatory preparation for external application
12/23/2009	WO2009154147A1 Oxybuprocaine-containing analgesic/antipruritic preparation for external application
12/23/2009	WO2009154132A1 Spirodiamine-diarylketoxime derivative
12/23/2009	WO2009154041A1 Method for producing morphine
12/23/2009	WO2009154014A1 External composition
12/23/2009	WO2009153972A1 Agent for prevention of or protection against hypoxic damage comprising mirna as active ingredient
12/23/2009	WO2009153897A1 Stemonamide synthesis intermediate and pharmaceutical composition for prevention and/or treatment of cancer
12/23/2009	WO2009153888A1 Drug carrier
12/23/2009	WO2009153791A1 Antiviral terpenoid compounds
12/23/2009	WO2009153782A1 Substituted cyclohexylidene-ethylidene-octahydro-indene compounds
12/23/2009	WO2009153721A1 Nicotinamide derivatives
12/23/2009	WO2009153720A1 Nicotinamide derivatives
12/23/2009	WO2009153704A1 Concentrated oxaliplatin solution and its method of preparation
12/23/2009	WO2009153665A2 Inhibitors of the shiga toxins trafficking through the retrograde pathway
12/23/2009	WO2009153654A1 Solid dosage forms of antiretrovirals
12/23/2009	WO2009153649A1 Process for preparing 3-substituted pyrrolidine compounds
12/23/2009	WO2009153634A1 A transmucosal delivery system
12/23/2009	WO2009153632A1 A gastroretentive pharmaceutical dosage form
12/23/2009	WO2009153597A2 Composition and process - 356
12/23/2009	WO2009153592A1 Pyrazole compounds 436
12/23/2009	WO2009153589A1 Pyridine compounds
12/23/2009	WO2009153569A2 Cb1 receptor modulators
12/23/2009	WO2009153566A1 Cyp26 inhibitors
12/23/2009	WO2009153554A1 Thieno-pyridine derivatives as mek inhibitors
12/23/2009	WO2009153536A1 1-aza-bicyclo [2.2.2] octane derivatives useful as muscarinic receptor antagonists
12/23/2009	WO2009153529A1 Biosourced acrolein polymer, method for obtaining same, and uses thereof
12/23/2009	WO2009153516A1 Novel derivatives of pyrroloindole inhibitors of hsp90, compositions containing same, and use thereof
12/23/2009	WO2009153514A1 Phenyl-alkyl piperazines having a modulating activity of tnf
12/23/2009	WO2009153459A1 Combination of a tiliroside and a peptide
12/23/2009	WO2009153448A1 Oral composition containing an anti-plaque agent of the thienopyridine family in the form of a base
12/23/2009	WO2009153346A2 Stabilization of amorphous drugs using sponge-like carrier matrices
12/23/2009	WO2009153319A1 Anti-tumour compositions and methods
12/23/2009	WO2009153313A1 2 -arylaminoquinazolines for treating proliferative diseases
12/23/2009	WO2009153307A1 Compounds
12/23/2009	WO2009153305A2 Pharmaceutical compositions of montelukast sodium
12/23/2009	WO2009153297A1 New trinem antibiotics and inhibitors of beta-lactamases
12/23/2009	WO2009153296A1 Pharmaceutical composition comprising a non-steroidal glucocorticoid receptor agonist in combination with a dual histamine antagonist
12/23/2009	WO2009153291A1 Combination of pilocarpin and methimazol for treating charcot-marietooth disease and related disorders
12/23/2009	WO2009153261A1 HYDROXYPHENYL-SUBSTITUTED PYRROLO[2,3d]PYRIMIDINE DERIVATIVES, PROCESSES AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE COMPOUNDS
12/23/2009	WO2009153226A1 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases
12/23/2009	WO2009153200A1 Preparation containing glucosamine and/or chondroitin for prophylaxis and treatment of arthrosis and for supporting the immune system
12/23/2009	WO2009153197A1 Halo-substituted pyrimidodiazepines as plkl inhibitors
12/23/2009	WO2009153182A1 Novel heteroaryl carboxamide derivatives
12/23/2009	WO2009153180A1 Heteroaromatic monoamides as orexinin receptor antagonists
12/23/2009	WO2009153179A1 Pyrrolidine derivatives as nk2 receptor antagonists
12/23/2009	WO2009153043A1 Combinations comprising methotrexate and dhodh inhibitors
12/23/2009	WO2009153009A1 Taxifolin derivatives for the prophylaxis and treatment of neurological and psychiatric disorders of the central nervous system
12/23/2009	WO2009152920A1 3-(3-pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazine derivatives as met kinase inhibitors
12/23/2009	WO2009152917A2 Stabilization of the composition of a mixture
12/23/2009	WO2009152909A1 Quinoxalinedione derivatives
12/23/2009	WO2009152868A1 6-1h-imidazo-quinazoline and quinolines derivatives, new mao inhibitors and imidazoline receptor ligands
12/23/2009	WO2009152825A1 Novel phenylimidazole derivatives as pde10a enzyme inhibitors
12/23/2009	WO2009152824A1 Heterocyclic derivatives as iap binding compounds
12/23/2009	WO2009152777A1 A stable and release-controlled rasagiline transdermal patch and method of preparation thereof
12/23/2009	WO2009152735A1 Histone deacetylase inhibitors and uses thereof
12/23/2009	WO2009152724A1 Use of paederosidic acid methyl ester in manufacture of medicaments for treating pain and/or inflammation.
12/23/2009	WO2009152712A1 Vinflunine salts, preparation process and pharmaceutical composition thereof
12/23/2009	WO2009152684A1 Crystalline of eszopiclone, its composition, preparation and uses thereof
12/23/2009	WO2009152665A1 A pharmaceutical composition for treating diabetes
12/23/2009	WO2009152647A1 Aralkyl piperidine derivatives and their uses as antalgic or ataractic agent
12/23/2009	WO2009152597A2 Topical use composition for combatting ectoparasites in dogs and cats
12/23/2009	WO2009152589A1 Use of paf receptor for treating infections caused by flaviviridae
12/23/2009	WO2009152584A1 Synthesis of ageladine a and analogs thereof
12/23/2009	WO2009152551A1 Pharmaceutical formulation
12/23/2009	WO2009136884A3 Metformin-pioglitazone formulation with antihyperglycemic effects
12/23/2009	WO2009136398A3 Stable benzimidazole formulation
12/23/2009	WO2009134995A3 Tetrazole compounds for reducing uric acid
12/23/2009	WO2009134725A3 Monomethylamine progesteron antagonists such as cdb-4453 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer etc
12/23/2009	WO2009133470A3 Use of dronedarone alone or in combination for preparing a medicament for the treatment of patients with arrhythmia and having an increase of creatinine level

1 ... 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 ... 7860